Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000702113 | SCV000830948 | pathogenic | Ornithine carbamoyltransferase deficiency | 2022-11-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. ClinVar contains an entry for this variant (Variation ID: 97333). This missense change has been observed in individuals with ornithine transcarbamylase deficiency (PMID: 8365726, 9286441, 12083811). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 268 of the OTC protein (p.Met268Thr). |
Revvity Omics, |
RCV000702113 | SCV002020194 | likely pathogenic | Ornithine carbamoyltransferase deficiency | 2020-08-10 | criteria provided, single submitter | clinical testing | |
Gen |
RCV000083580 | SCV000115666 | pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Pathogenic. |